The University of Chicago Header Logo

Connection

Eric Pamer to Anti-Bacterial Agents

Back to Details
This is a "connection" page, showing publications Eric Pamer has written about Anti-Bacterial Agents.
Eric Pamer
Connection Strength
4.915
Anti-Bacterial Agents
  1. TAM mediates adaptation of carbapenem-resistant Klebsiella pneumoniae to antimicrobial stress during host colonization and infection. PLoS Pathog. 2021 02; 17(2):e1009309.
    View in: PubMed
    Score: 0.486
  2. Impact of Antibiotic-Resistant Bacteria on Immune Activation and Clostridioides difficile Infection in the Mouse Intestine. Infect Immun. 2020 03 23; 88(4).
    View in: PubMed
    Score: 0.458
  3. Genome-Wide Screening for Enteric Colonization Factors in Carbapenem-Resistant ST258 Klebsiella pneumoniae. mBio. 2019 03 12; 10(2).
    View in: PubMed
    Score: 0.426
  4. The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens. Immunol Rev. 2017 Sep; 279(1):90-105.
    View in: PubMed
    Score: 0.383
  5. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med. 2016 06; 22(6):458-478.
    View in: PubMed
    Score: 0.350
  6. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science. 2016 Apr 29; 352(6285):535-8.
    View in: PubMed
    Score: 0.349
  7. Antibiotics, microbiota, and immune defense. Trends Immunol. 2012 Sep; 33(9):459-66.
    View in: PubMed
    Score: 0.267
  8. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun. 2012 Jan; 80(1):62-73.
    View in: PubMed
    Score: 0.255
  9. Intestinal carbapenem-resistant Klebsiella pneumoniae undergoes complex transcriptional reprogramming following immune activation. Gut Microbes. 2024 Jan-Dec; 16(1):2340486.
    View in: PubMed
    Score: 0.152
  10. Antibiotic Degradation by Commensal Microbes Shields Pathogens. Infect Immun. 2020 03 23; 88(4).
    View in: PubMed
    Score: 0.114
  11. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Nature. 2019 08; 572(7771):665-669.
    View in: PubMed
    Score: 0.110
  12. Enlisting commensal microbes to resist antibiotic-resistant pathogens. J Exp Med. 2019 01 07; 216(1):10-19.
    View in: PubMed
    Score: 0.103
  13. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med. 2018 09 26; 10(460).
    View in: PubMed
    Score: 0.103
  14. Commensal microbes provide first line defense against Listeria monocytogenes infection. J Exp Med. 2017 Jul 03; 214(7):1973-1989.
    View in: PubMed
    Score: 0.094
  15. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017 May; 23(5):845-852.
    View in: PubMed
    Score: 0.092
  16. Short- and long-term effects of oral vancomycin on the human intestinal microbiota. J Antimicrob Chemother. 2017 01; 72(1):128-136.
    View in: PubMed
    Score: 0.090
  17. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol. 2016 10; 14(10):609-20.
    View in: PubMed
    Score: 0.089
  18. Microbiome mediation of infections in the cancer setting. Genome Med. 2016 Apr 18; 8(1):40.
    View in: PubMed
    Score: 0.087
  19. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint? Clin Infect Dis. 2016 06 15; 62(12):1514-1520.
    View in: PubMed
    Score: 0.087
  20. Role of intestinal microbiota in transplantation outcomes. Best Pract Res Clin Haematol. 2015 Jun-Sep; 28(2-3):155-61.
    View in: PubMed
    Score: 0.084
  21. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015 Jan 08; 517(7533):205-8.
    View in: PubMed
    Score: 0.079
  22. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013 Nov; 13(11):790-801.
    View in: PubMed
    Score: 0.073
  23. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J Exp Med. 2012 Jul 30; 209(8):1445-56.
    View in: PubMed
    Score: 0.067
  24. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010 Dec; 120(12):4332-41.
    View in: PubMed
    Score: 0.060
  25. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis. 2010 Feb 15; 201(4):534-43.
    View in: PubMed
    Score: 0.057
  26. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study. Clin Infect Dis. 2004 Dec 01; 39(11):1625-32.
    View in: PubMed
    Score: 0.039
  27. Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals. ACS Chem Biol. 2024 02 16; 19(2):357-369.
    View in: PubMed
    Score: 0.037
  28. Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049.
    View in: PubMed
    Score: 0.037
  29. The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremia. Cell Host Microbe. 2023 07 12; 31(7):1126-1139.e6.
    View in: PubMed
    Score: 0.036
  30. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients. Cell. 2023 06 08; 186(12):2705-2718.e17.
    View in: PubMed
    Score: 0.036
  31. Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation. Antimicrob Agents Chemother. 2003 Jun; 47(6):1818-23.
    View in: PubMed
    Score: 0.036
  32. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clin Infect Dis. 2002 Aug 01; 35(3):E35-6.
    View in: PubMed
    Score: 0.033
  33. Outbreaks of Typhlocolitis Caused by Hypervirulent Group ST1 Clostridioides difficile in Highly Immunocompromised Strains of Mice. Comp Med. 2020 06 01; 70(3):277-290.
    View in: PubMed
    Score: 0.029
  34. Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study. Transpl Infect Dis. 2019 Dec; 21(6):e13180.
    View in: PubMed
    Score: 0.028
  35. Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium. Cell Host Microbe. 2017 May 10; 21(5):592-602.e4.
    View in: PubMed
    Score: 0.023
  36. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016 05 18; 8(339):339ra71.
    View in: PubMed
    Score: 0.022
  37. Commensal microbiota affects ischemic stroke outcome by regulating intestinal ?d T cells. Nat Med. 2016 05; 22(5):516-23.
    View in: PubMed
    Score: 0.022
  38. Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae. PLoS Pathog. 2015 Sep; 11(9):e1005132.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.